Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 33
Titolo Autore(i) Anno Periodico Editore Tipo File
The promise of liquid biopsy in cancer: A clinical perspective Cortesi E.; Palleschi M.; Magri V.; Naso G. 2015-01-01 CHINESE JOURNAL OF CANCER RESEARCH - 1.01 Articolo in rivista -
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer Gamucci T.; Mentuccia L.; Natoli C.; Sperduti I.; Cassano A.; Michelotti A.; Di Lauro L.; Sergi D....; Fabi A.; Sarobba M.G.; Marchetti P.; Barba M.; Magnolfi E.; Maugeri-Sacca M.; Rossi E.; Sini V.; Grassadonia A.; Pellegrini D.; Astone A.; Nistico C.; Angelini F.; Vaccaro A.; Pellegrino A.; De Angelis C.; Palleschi M.; Moscetti L.; Bertolini I.; Buglioni S.; Giordano A.; Pizzuti L.; Vici P. 2017-01-01 JOURNAL OF CELLULAR PHYSIOLOGY - 1.01 Articolo in rivista Journal Cellular Physiology - 2016 - Gamucci - A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and.pdf
Ribociclib and endocrine therapy in breast cancer Rocca A.; Melegari E.; Palleschi M. 2019-01-01 THE NEW ENGLAND JOURNAL OF MEDICINE - 1.04 Replica / breve intervento (e simili) -
Precision medicine: PI3K targeting in advanced breast cancer Rocca A.; Melegari E.; Palleschi M. 2019-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.04 Replica / breve intervento (e simili) -
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer Maltoni R.; Palleschi M.; Ravaioli S.; Tumedei M.M.; Rocca A.; Melegari E.; Altini M.; Puccetti M....; Manunta S.; Bravaccini S. 2020-01-01 CELL TRANSPLANTATION - 1.01 Articolo in rivista maltoni-et-al-2020.pdf
Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report Palleschi M.; Maltoni R.; Barzotti E.; Melegari E.; Curcio A.; Cecconetto L.; Sarti S.; Manunta S....; Rocca A. 2020-01-01 WORLD JOURNAL OF CLINICAL CASES - 1.04 Replica / breve intervento (e simili) -
Are we ready to use TMB in breast cancer clinical practice? Ravaioli S.; Limarzi F.; Tumedei M.M.; Palleschi M.; Maltoni R.; Bravaccini S. 2020-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.04 Replica / breve intervento (e simili) -
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer? Palleschi M.; Maltoni R.; Sarti S.; Melegari E.; Bravaccini S.; Rocca A. 2020-01-01 THE BREAST JOURNAL - 1.04 Replica / breve intervento (e simili) -
Atezolizumab plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter Bravaccini S.; Ravaioli S.; Tumedei M.M.; Rocca A.; Palleschi M.; Puccetti M.; Parrella P.; Altin...i M.; Maltoni R. 2020-01-01 CLINICAL CANCER RESEARCH - 1.04 Replica / breve intervento (e simili) -
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? Maltoni R.; Palleschi M.; Altini M.; Massa I.; Balzi W.; Ravaioli S.; Tumedei M.M.; Rocca A.; Bra...vaccini S. 2020-01-01 CLINICAL BREAST CANCER - 1.04 Replica / breve intervento (e simili) -
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei ...M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S. 2020-01-01 DIAGNOSTICS - 1.01 Articolo in rivista Ki67 and PR in Patients Treated with CDK4 6.pdf
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives Brighi N.; Conteduca V.; Lolli C.; Gurioli G.; Schepisi G.; Palleschi M.; Mariotti M.; Casadei C....; De Giorgi U. 2021-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial Fabi A, Terrenato I, Vidiri A, Villani V, Tanzilli A, Airoldi M, Pedani F, Magri V, Palleschi M, ...Donadio M, Catania G, Nisticò C, Carapella C, Rudà R, Pace A, Maschio M, Telera S, Cognetti F; 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) Vernieri C.; Nichetti F.; Lalli L.; Moscetti L.; Giorgi C.A.; Griguolo G.; Marra A.; Randon G.; R...ea C.G.; Ligorio F.; Scagnoli S.; De Angelis C.; Molinelli C.; Fabbri A.; Ferraro E.; Trapani D.; Milani A.; Agostinetto E.; Bernocchi O.; Catania G.; Vantaggiato A.; Palleschi M.; Moretti A.; Basile D.; Cinausero M.; Ajazi A.; Castagnoli L.; Vullo S.L.; Gerratana L.; Puglisi F.; La Verde N.; Arpino G.; Rocca A.; Ciccarese M.; Pedersini R.; Fabi A.; Generali D.; Losurdo A.; Montemurro F.; Curigliano G.; Del Mastro L.; Michelotti A.; Cortesi E.; Guarneri V.; Pruneri G.; Mariani L.; De Braud F. 2021-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
Moving beyond parp inhibition: Current state and future perspectives in breast cancer Palleschi M.; Tedaldi G.; Sirico M.; Virga A.; Ulivi P.; De Giorgi U. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-07884-v3.pdf
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. 2021-01-01 ESMO OPEN - 1.01 Articolo in rivista -
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor Palleschi M.; Iaia M.L.; Casadei C. 2021-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.04 Replica / breve intervento (e simili) -
Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough? Palleschi M.; Scarpi E.; Casadei C. 2021-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.01 Articolo in rivista -
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; ...Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A. 2022-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista -
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna;... Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista graphic.pdfijms-23-14197.pdf
Mostrati risultati da 1 a 20 di 33
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile